NEW YORK -- A course of pills developed by Pfizer can slash the risk of being hospitalized or dying from COVID-19 by 89% if taken within three days of developing symptoms, according to results ...

WASHINGTON - U.S. health regulators on Thursday authorized Merck’s COVID-19 pill, known as molnupiravir — the second medication approved for at-home use to battle the rapidly-spreading omicron variant ...

This transcript was prepared by a transcription service. This version may not be in its final form and may be updated. Kate Linebaugh: Our colleague, Jared Hopkins, has been following a promising ...

NEW YORK -- When Laura Martin tested positive for COVID-19 last month during an extended stay in California, she was prescribed Paxlovid, the highly touted antiviral drug created by Pfizer. Just one ...

Pfizer said Tuesday it signed a licensing agreement to allow broader global access to its experimental COVID-19 pill. The agreement with the Medicines Patent Pool, a United Nations-backed public ...

The FDA said Friday that Merck's anti-COVID-19 pill is effective in treating the virus but said that regulators will meet next week to investigate whether the pill is safe for people who are pregnant ...

Researchers continue looking at existing medicine for help in the fight against the novel coronavirus, because those drugs already exist and could quickly make a big difference. The latest lead for ...

*This Wednesday, the FDA announced that it has authorized Pfizer‘s antiviral pills to treat COVID-19 for emergency use, which allows limited use of the drug in Americans as young as 12 who are at ...

NEW YORK (WABC) -- With two new pills now authorized by the FDA to fight the effects of COVID, there's a push for New York state to be first in line for the initial shipments. Supplies of Pfizer's ...

Researchers are launching a new study to investigate whether GLP-1 drugs, already approved for type 2 diabetes and obesity, could help treat long COVID symptoms. The medications are currently being ...

Add Yahoo as a preferred source to see more of our stories on Google. By now, most people have reached a resigned acceptance when it comes to COVID-19. We accept that we’re probably going to get ...